[1
]
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
[2
]
Institute of Global Health, University of Siena, Siena, Italy; Department of Paediatrics,
University of Oxford, Oxford, UK.
[3
]
South African Medical Research Council Vaccines and Infectious Diseases Analytics
Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,
South Africa; Department of Science and Innovation/National Research Foundation South
African Research Chair Initiative in Vaccine Preventable Diseases Unit, University
of the Witwatersrand, Johannesburg, South Africa.
[4
]
Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
[5
]
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
[6
]
Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch,
Cape Town, South Africa.
[7
]
Soweto Clinical Trials Centre, Soweto, South Africa.
[8
]
Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand,
Johannesburg, South Africa.
[9
]
Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool
University Hospitals NHS Foundation Trust, Liverpool, UK.
[10
]
Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield,
Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals
NHS Foundation Trust, Sheffield, UK.
[11
]
Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, Cape
Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology
and Infection, London School of Hygiene & Tropical Medicine, London, UK.
[12
]
Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation
Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity
and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.
[13
]
Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University
of the Witwatersrand, Johannesburg, South Africa.
[14
]
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University
Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton,
UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton,
Southampton, UK.
[15
]
School of Population Health Sciences, University of Bristol and University Hospitals
Bristol and Weston NHS Foundation Trust, UK.
[16
]
St George's Vaccine Institute, St George's, University of London, London, UK.
[17
]
Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital,
London, UK; MRC Clinical Trials Unit, University College London, London, UK.
[18
]
Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.
[19
]
NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS
Foundation Trust, Birmingham, UK.
[20
]
AstraZeneca BioPharmaceuticals, Cambridge, UK.
[21
]
Severn Pathology, North Bristol NHS Trust, Bristol, UK.
[22
]
NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London,
UK.
[23
]
Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK.
[24
]
Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael,
Salvador, Brazil; Instituto D'Or, Salvador, Brazil.
[25
]
Universidade Federal do Rio Grande do Norte, Natal, Brazil.
[26
]
London Northwest University Healthcare, Harrow, UK.
[27
]
Setshaba Research Centre, Pretoria, South Africa.
[28
]
Hospital Quinta D'Or, Rede D'Or, Rio De Janeiro, Brazil.
[29
]
NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre,
London, UK.
[30
]
Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa
Maria, Santa Maria, Brazil.
[31
]
College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School,
University of Glasgow, Glasgow, UK.
[32
]
Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal
do Rio Grande do Sul, Porto Alegre, Brazil.
[33
]
Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General
Hospital, Edinburgh, UK.
[34
]
MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases,
Queen Elizabeth University Hospital, Glasgow, UK.
[35
]
Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals
NHS Foundation Trust, Cambridge, UK.
[36
]
Heart Lung Research Institute, Dept of Medicine, University of Cambridge and NIHR
Cambridge Clinical Research Facility, Cambridge University Hospital and Royal Papworth
NHS Foundation Trusts, Cambridge, UK.
[37
]
University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham,
UK.
[38
]
Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport,
Wales.
[39
]
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
